Merck and Huma Therapeutics launch innovative app to support bladder cancer patients

London headquartered Huma Therapeutics, together with Germany's Merck KGaA, has announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom.

Read more in the latest MedTech Spectrum blog here.

Previous post
Back to list
Next post